Basophilic staining of vascular walls due to encrustation by DNA from necrotic tumour cells is seen in which of the following variants of lung cancer?
A 25-year-old woman presents with progressive dyspnea and fatigue over the past 2 years. Physical examination reveals pedal edema, jugular venous distention, and hepatomegaly. Lung auscultation is clear. A chest CT scan shows right heart enlargement. Cardiac catheterization demonstrates increased pulmonary arterial pressure without pulmonic valve gradients and no shunts. A transbronchial biopsy reveals plexiform lesions. A mutation in a gene encoding for which of the following is most likely responsible for her pulmonary disease?
Which of the following is NOT a feature of bronchial asthma?
Charcot-Leyden crystals and Curshmann's spirals are seen in which of the following conditions?
How is pulmonary infarction differentiated from pulmonary edema?
Bronchoalveolar carcinoma presents as:
A 30-year-old man undergoes a lung biopsy, which shows multiple nodular lesions consisting of large epithelioid cells surrounded by lymphocytes and fibroblasts. There is an area of necrosis in the center of some nodules. Numerous acid-fast bacilli are demonstrated by Ziehl-Neelsen staining within the cytoplasm of epithelioid cells. Silver stains for fungi are negative. Which of the following is the MOST likely condition that predisposed the patient to this pulmonary disease?
What is the primary site of involvement in congenital tuberculosis?
A 64-year-old man with a history of occupational exposure presents with an 8-month history of chest discomfort, malaise, fever, night sweats, and weight loss. Imaging reveals a pleural effusion and a pleural mass encasing the lung. The patient died of cardiorespiratory failure. Histologic examination of the pleural mass shows a biphasic pattern of epithelial and sarcomatous elements. What is the most likely diagnosis?
Few RBCs, raised neutrophils with some hemorrhage in alveoli is seen in which stage of pneumonia?
Explanation: ### Explanation The phenomenon described in the question is known as the **Azzopardi Effect**. This is a classic histopathological hallmark of **Small Cell Carcinoma (SCLC)** of the lung. **Why Small Cell Variant is Correct:** Small cell carcinoma is characterized by extremely fragile, hyperchromatic cells with a high nuclear-to-cytoplasmic (N:C) ratio and a very high mitotic rate [1]. Due to rapid cell turnover and fragility, these cells undergo extensive necrosis. During this process, the DNA from the broken nuclei is released and gets encrusted onto the walls of nearby blood vessels. Because DNA is acidic, it stains intensely blue/purple with Hematoxylin, leading to the characteristic **basophilic staining of vascular walls**. **Why Other Options are Incorrect:** * **Squamous Cell Carcinoma:** Typically shows keratinization, intercellular bridges, and "keratin pearls." While necrosis can occur (central cavitation), the specific DNA encrustation of vessels is not a feature. * **Adenocarcinoma:** Characterized by gland formation and mucin production. It does not typically exhibit the extreme nuclear fragility required for the Azzopardi effect. * **Large Cell Carcinoma:** Composed of large, undifferentiated cells with prominent nucleoli [1]. While it is aggressive, it lacks the specific "small cell" fragility and DNA leaching pattern. **High-Yield Clinical Pearls for NEET-PG:** * **Azzopardi Effect:** Most commonly associated with **Small Cell Carcinoma** (Lung) and sometimes seen in Merkel cell carcinoma or lymphomas. * **Origin:** SCLC arises from **neuroendocrine (Kulchitsky) cells** [1]. * **Markers:** Positive for Chromogranin A, Synaptophysin, and CD56. * **Paraneoplastic Syndromes:** SCLC is frequently associated with SIADH, ACTH production (Cushing’s), and Lambert-Eaton Myasthenic Syndrome [2]. * **Genetics:** Strongest association with smoking; almost universal loss of **TP53** and **RB1** genes. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 337-338. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 725-727.
Explanation: ### Explanation **1. Why BMPR2 is Correct:** The clinical presentation describes **Primary Pulmonary Arterial Hypertension (PAH)**. The patient is a young female with signs of right-sided heart failure (cor pulmonale: pedal edema, JVD, hepatomegaly) and elevated pulmonary pressures in the absence of secondary causes (clear lungs, no shunts). The pathognomonic histological finding is the **plexiform lesion** (a tuft of capillary formations producing a network that spans the lumen of small arteries). Approximately 75% of familial PAH cases and 25% of sporadic cases are associated with germline mutations in the **Bone Morphogenetic Protein Receptor Type 2 (BMPR2)** gene [1]. BMPR2 is a member of the TGF-β receptor family. Normally, BMPR2 signaling inhibits the proliferation of vascular smooth muscle cells. A "loss-of-function" mutation leads to uncontrolled proliferation of endothelial and smooth muscle cells, resulting in vascular remodeling and luminal narrowing. **2. Why Incorrect Options are Wrong:** * **A. BNP:** While BNP levels are elevated in heart failure as a response to ventricular stretch, mutations in the BNP gene do not cause pulmonary hypertension. * **C. eNOS:** Although decreased nitric oxide (a vasodilator) contributes to the pathogenesis of PAH, primary mutations in the eNOS gene are not the established genetic basis for familial PAH [1]. * **D. Fibrillin-1:** Mutations in Fibrillin-1 cause **Marfan Syndrome**, which is associated with aortic aneurysms and dissections, not primary plexiform pulmonary hypertension. **3. High-Yield Clinical Pearls for NEET-PG:** * **Demographics:** Classically affects young women (20–40 years). * **Histology Sequence:** Medial hypertrophy → Intimal fibrosis (onion-skinning) → **Plexiform lesions** (late-stage/irreversible). * **Genetics:** Autosomal dominant inheritance with **incomplete penetrance** (only ~20% of carriers develop clinical disease). * **Treatment Target:** Endothelin receptor antagonists (e.g., Bosentan), PDE-5 inhibitors (e.g., Sildenafil), or Prostacyclin analogues (e.g., Epoprostenol) [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 324-325.
Explanation: **Explanation:** The question asks for the feature **NOT** typically associated with the classic histopathological and immunological profile of bronchial asthma. **Why Option A is the Correct Answer:** While it may seem counterintuitive, "Thickening of bronchial wall" is considered a less specific or technically incorrect descriptor compared to the precise remodeling changes. In the context of asthma, the specific change is **subepithelial fibrosis** (thickening of the basement membrane) rather than a generalized thickening of the entire bronchial wall [1]. In many standardized pathology exams, "thickening of the basement membrane" is the hallmark; generalized wall thickening is more characteristic of chronic bronchitis. **Analysis of Incorrect Options:** * **B. Increase in number of goblet glands:** This is a classic feature of airway remodeling in asthma. Goblet cell hyperplasia leads to excessive mucus production, contributing to the formation of Curschmann spirals [1]. * **C. Hypertrophy of smooth muscle:** Chronic inflammation leads to the hypertrophy and hyperplasia of bronchial smooth muscle, which causes airway hyper-responsiveness and bronchoconstriction [1]. * **D. Increased IgE:** Atopic (extrinsic) asthma is a Type I hypersensitivity reaction [2]. Exposure to allergens triggers Th2 cells to release IL-4 and IL-5, leading to B-cell class switching to IgE, which coats mast cells [2]. **High-Yield NEET-PG Pearls:** * **Charcot-Leyden Crystals:** Composed of eosinophil protein (galectin-10). * **Curschmann Spirals:** Whorls of shed epithelium found in mucus plugs [1]. * **Creola Bodies:** Clusters of exfoliated bronchial epithelial cells. * **Key Cytokines:** IL-4 (IgE production), IL-5 (eosinophil activation), and IL-13 (mucus secretion) [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 328-329. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 686-689.
Explanation: **Explanation:** The presence of **Charcot-Leyden crystals** and **Curschmann’s spirals** in sputum is a classic pathological hallmark of **Bronchial Asthma** [1]. * **Curschmann’s spirals** are microscopic mucus plugs shaped like spirals. They are formed from the inspissated (thickened) mucus of the subepithelial mucous gland ducts or bronchioles, often containing shed epithelium [1]. * **Charcot-Leyden crystals** are eosinophil-derived structures. They are composed of **Galectin-10** (previously thought to be lysophospholipase), which is released during the degranulation of eosinophils—the primary effector cells in the type I hypersensitivity reaction of asthma [1]. **Analysis of Incorrect Options:** * **Chronic Bronchitis:** Characterized by a chronic productive cough and hypertrophy of mucus-secreting glands (increased Reid Index). While mucus is present, these specific crystalline and spiral structures are absent. * **Bronchiectasis:** Involves permanent dilation of bronchi due to chronic infection [1]. Sputum is typically foul-smelling and purulent (containing pus), but not characterized by eosinophilic crystals. * **Emphysema:** Defined by the permanent enlargement of airspaces distal to the terminal bronchioles. It is a disease of alveolar wall destruction rather than airway inflammation/obstruction involving eosinophils. **High-Yield Clinical Pearls for NEET-PG:** * **Creola bodies:** Another finding in asthma; these are ciliated columnar epithelial cell clusters shed from the bronchial mucosa. * **Reid Index:** Used for Chronic Bronchitis (Ratio of gland thickness to wall thickness; Normal <0.4). * **Kartagener Syndrome:** A common NEET-PG trigger associated with Bronchiectasis (triad of situs inversus, sinusitis, and bronchiectasis). * **Alpha-1 Antitrypsin Deficiency:** Associated with panacinar emphysema, especially in the lower lobes. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 687-691.
Explanation: **Explanation:** The differentiation between pulmonary infarction and pulmonary edema relies on identifying the underlying pathophysiology of the extravasated red blood cells (RBCs). **1. Why "Heart Failure Cells" is correct:** Heart failure cells are **hemosiderin-laden macrophages** found in the alveoli. In chronic pulmonary congestion (often due to Left Heart Failure), increased hydrostatic pressure causes RBCs to leak into the alveolar spaces [1]. Alveolar macrophages phagocytose these RBCs and convert the hemoglobin into golden-brown hemosiderin pigment [1]. While both conditions involve blood in the lungs, the presence of these specific macrophages is a hallmark of **chronic passive congestion (pulmonary edema)**, whereas acute pulmonary infarction typically shows fresh hemorrhage and tissue necrosis without the time required for macrophage transformation. **2. Why other options are incorrect:** * **B. Necrotizing alveolar sac:** This is a feature of pulmonary infarction (coagulative necrosis due to ischemia), but it is not the primary diagnostic marker used to differentiate it from edema in this context. * **C. Capillary congestion:** This is a non-specific finding seen in both acute pulmonary edema and the early stages of infarction [1]. It does not help distinguish between the two. * **D. Pulmonary wedge pressure:** While this is a clinical measurement used to diagnose cardiogenic pulmonary edema (elevated >18 mmHg), it is a hemodynamic parameter, not a pathological/histological feature used to differentiate tissue samples. **Clinical Pearls for NEET-PG:** * **Prussian Blue Stain:** Used to confirm the presence of iron (hemosiderin) in heart failure cells. * **Brown Induration:** Chronic pulmonary congestion leads to "brown induration" of the lungs due to hemosiderin deposition and secondary fibrosis [1]. * **Nutmeg Liver:** Often co-exists with heart failure cells, representing chronic passive congestion of the liver [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 126.
Explanation: **Explanation:** Bronchoalveolar Carcinoma (BAC), now classified under the spectrum of **Adenocarcinoma in situ (AIS)** and **Minimally Invasive Adenocarcinoma (MIA)**, is a unique subtype of lung cancer that grows along the alveolar walls without invading the stroma (lepidic growth pattern) [1]. **Why "All of the Above" is correct:** BAC can present in three distinct patterns: a solitary peripheral nodule, a multinodular form, or a diffuse pneumonic-type consolidation. 1. **Hemoptysis:** Like all bronchogenic carcinomas, erosion into small vessels or irritation of the airway can lead to blood-streaked sputum. 2. **Collapse (Atelectasis):** Although BAC typically spreads along alveolar walls, the diffuse or multinodular forms can lead to significant airway obstruction or replacement of air spaces with mucin/tumor cells, resulting in segmental or lobar collapse [1]. 3. **Effusion:** BAC has a high propensity for pleural involvement. The peripheral location of the tumor often leads to malignant pleural effusions due to direct extension or lymphatic spread [1]. **Clinical Pearls for NEET-PG:** * **Lepidic Growth:** The hallmark histological feature where tumor cells "crawl" along pre-existing alveolar structures [1]. * **Bronchorrhea:** A classic, high-yield clinical sign where the patient produces massive amounts of watery, mucoid sputum (seen in the mucinous subtype). * **Radiology:** Often mimics **lobar pneumonia** on a chest X-ray (consolidation that does not resolve with antibiotics). * **Driver Mutations:** Frequently associated with **EGFR mutations**, making it more common in non-smokers, females, and Asians. * **Prognosis:** It generally has a better prognosis than other bronchogenic carcinomas if detected in the solitary nodule stage. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 335-337.
Explanation: The clinical presentation describes **Tuberculosis (TB)**, characterized by necrotizing (caseating) granulomas containing epithelioid cells, lymphocytes, and acid-fast bacilli (AFB) [1]. **Why Option A is Correct:** In a 30-year-old patient, the presence of **numerous** acid-fast bacilli within the cytoplasm of epithelioid cells is a high-yield indicator of an immunocompromised state, specifically **AIDS** [1]. In immunocompetent individuals, the cell-mediated immune response (Th1 cells and IFN-̳) effectively "activates" macrophages to kill the bacteria, resulting in a low bacterial load (paucibacillary) [1]. In AIDS, the depletion of CD4+ T-cells leads to a failure of macrophage activation, allowing the *Mycobacterium tuberculosis* to proliferate unchecked, resulting in a **multibacillary** state as described in the question [2]. **Why Other Options are Incorrect:** * **B. Common Variable Immunodeficiency (CVID):** Primarily involves B-cell defects and hypogammaglobulinemia, predisposing patients to pyogenic sinopulmonary infections (e.g., *S. pneumoniae*), not typically disseminated or high-load TB. * **C. Cystic Fibrosis:** Predisposes to bronchiectasis and colonization by *Pseudomonas aeruginosa* or *Staphylococcus aureus* [3], rather than granulomatous TB. * **D. Depressed level of consciousness:** This is a major risk factor for **aspiration pneumonia** (often anaerobic or polymicrobial) and lung abscesses, not primary TB. **High-Yield NEET-PG Pearls:** * **Granuloma Composition:** Epithelioid cells (activated macrophages), Langhans giant cells (fused macrophages), and a peripheral rim of T-lymphocytes [1]. * **Ghon Complex:** Subpleural lesion (Ghon focus) + Hilar lymph node involvement; characteristic of primary TB. * **Anergy:** In advanced AIDS, the Mantoux (TST) test may be negative despite active TB because the patient cannot mount a delayed-type hypersensitivity response [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 380-384. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 382-383. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 320-321.
Explanation: **Explanation:** The primary site of involvement in congenital tuberculosis is the **Liver**. This is a high-yield concept based on the unique fetal circulatory pathway. **Why the Liver is the correct answer:** Congenital tuberculosis is acquired *in utero* via the placenta. The tubercle bacilli (Mycobacterium tuberculosis) enter the fetal circulation through the **umbilical vein**. Since the umbilical vein drains directly into the fetal liver (via the left portal vein and ductus venosus), the liver acts as the first filter for the infected blood. This leads to the formation of a **primary complex in the liver**, characterized by caseating granulomas and involvement of the periportal lymph nodes [1]. **Why the other options are incorrect:** * **Lungs:** In adults and children, the lungs are the primary site because infection is acquired via inhalation. In congenital TB, the lungs are only involved secondarily after the bacilli pass through the liver and enter the systemic circulation [2]. * **Lymph Nodes:** While periportal lymph nodes are involved as part of the primary complex, the liver parenchyma itself is the initial site of seeding. * **Stomach:** Infection of the stomach or gastrointestinal tract occurs if the fetus swallows infected amniotic fluid (*in utero* or during birth), but this is a less common route than the hematogenous umbilical vein route. **Clinical Pearls for NEET-PG:** * **Cantwell’s Criteria:** Used to diagnose congenital TB, distinguishing it from postnatal infection. * **Primary Complex Location:** In postnatal TB, the primary (Ghon) complex is in the **Lungs**. In congenital TB, the primary complex is in the **Liver** [1]. * **Route of Infection:** The most common route for congenital TB is **hematogenous** (transplacental), not aspiration of amniotic fluid. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 401-402. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 320-321.
Explanation: **Explanation:** The clinical presentation and histopathology point directly to **Malignant Mesothelioma**. **Why the correct answer is right:** 1. **Clinical Presentation:** The patient’s age, history of occupational exposure (strongly implying **asbestos**), and constitutional symptoms (weight loss, night sweats) are classic [2]. 2. **Imaging/Gross Findings:** A pleural mass **encasing the lung** (forming a thick "rind") is a hallmark of mesothelioma, distinguishing it from bronchogenic carcinomas which typically arise within the lung parenchyma. 3. **Histology:** The **biphasic pattern** is the pathognomonic histological feature of mesothelioma, consisting of both **epithelial** (cuboidal or columnar cells forming tubules/papillae) and **sarcomatous** (spindle-shaped cells) elements [1]. **Why incorrect options are wrong:** * **Carcinoid tumor:** These are neuroendocrine tumors typically presenting as endobronchial masses causing airway obstruction. Histology shows uniform cells in nests/trabeculae ("salt and pepper" chromatin), not a biphasic pleural mass. * **Large cell carcinoma:** An undifferentiated peripheral lung malignancy. It lacks the specific biphasic architecture and typically presents as a large parenchymal mass rather than a pleural rind. * **Malignant melanoma:** While it can metastasize to the pleura, it would not show a biphasic epithelial-sarcomatous pattern and is usually positive for markers like S100 and HMB-45 [3]. **High-Yield Pearls for NEET-PG:** * **Asbestos Exposure:** The most important risk factor (latent period: 25–40 years) [2]. Note: Asbestos is more commonly associated with **Bronchogenic Carcinoma**, but Mesothelioma is more **specific** to asbestos. * **IHC Markers:** Mesothelioma is typically **Calretinin (+)**, Cytokeratin 5/6 (+), and WT-1 (+). It is **CEA (-)**, which helps differentiate it from Adenocarcinoma [1]. * **Electron Microscopy:** Shows **long, slender microvilli** (Adenocarcinoma has short, blunt microvilli). * **Cytogenetics:** Often associated with deletions of **BAP1** gene. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 731. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 339-340. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 338-339.
Explanation: **Explanation:** The question describes the classic histopathological features of **Red Hepatization**, the second stage of lobar pneumonia [1]. **1. Why Red Hepatization is correct:** During this stage (typically days 2–4), the lung parenchyma undergoes massive confluent exudation [1]. The alveoli become packed with **neutrophils**, **fibrin**, and significantly, **extravasated Red Blood Cells (RBCs)** [1, 2]. The presence of these RBCs, along with vascular congestion, gives the lung a gross appearance similar to the liver (hence "hepatization") and a reddish hue [1, 2]. The hemorrhage into the alveolar spaces is the hallmark that distinguishes this stage from others [2]. **2. Why other options are incorrect:** * **Gray Hepatization:** In this subsequent stage, RBCs undergo lysis and disappear [1]. The exudate consists primarily of persistent fibrin and neutrophils [1, 2]. Grossly, the lung turns grayish-brown and dry. * **Viral Pneumonia:** This typically presents as **interstitial inflammation** rather than alveolar filling [1]. The predominant cells are lymphocytes and macrophages (mononuclear cells), not neutrophils. * **Resolving Phase:** This stage is characterized by the enzymatic digestion of the exudate by macrophages [1]. The alveolar architecture is restored, and the cellular debris is either coughed up or resorbed. **NEET-PG High-Yield Pearls:** * **Sequence of Stages:** Congestion (Day 1) → Red Hepatization (Day 2-4) → Gray Hepatization (Day 4-8) → Resolution (Day 8+) [1, 2]. * **Congestion Stage:** Characterized by "heavy, boggy, and red" lungs with vascular engorgement and intra-alveolar fluid with few bacteria [1, 2]. * **Rusty Sputum:** Clinically, the "Red Hepatization" stage corresponds to the classic "rusty sputum" seen in *Streptococcus pneumoniae* infections due to the breakdown of RBCs. * **Fibrinous Pleuritis:** Most common in the Red and Gray hepatization stages, leading to pleuritic chest pain [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 711-712, 715. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 317-318.
Congenital Anomalies
Practice Questions
Atelectasis and Acute Lung Injury
Practice Questions
Obstructive Pulmonary Diseases
Practice Questions
Restrictive Pulmonary Diseases
Practice Questions
Lung Infections
Practice Questions
Pulmonary Vascular Diseases
Practice Questions
Lung Tumors
Practice Questions
Pleural Diseases
Practice Questions
Interstitial Lung Diseases
Practice Questions
Occupational Lung Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free